Filter by: Subject
Now showing items 1-10 of 33
Análisis costo-beneficio (33) |
Eficacia (33) |
Corticoesteroides (3) |
Rituximab (3) |
Infliximab (2) |
Trombocitopenia (2) |
Adalimumab (1) |
Alemtuzumab (1) |
Alfa-glucosidasas (1) |
Amicacina (1) |
Análisis costo-beneficio (33) |
Eficacia (33) |
Corticoesteroides (3) |
Rituximab (3) |
Infliximab (2) |
Trombocitopenia (2) |
Adalimumab (1) |
Alemtuzumab (1) |
Alfa-glucosidasas (1) |
Amicacina (1) |